Financial PerformanceISRG's stock had a strong run through 2024, up almost +50%, with a strong finish to the year and solid guide keeping enthusiasm live.
Market GrowthStrong outside United States procedure growth reflects a continuation of the traction in non-urology procedures.
Technological AdvancementsDa Vinci 5 (dV5) takes robotics to standard of care by unlocking 10,000x computing power with AI/machine learning.